We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Urges Retesting Tissue Donors to Decrease Communicable Disease Risk
FDA Urges Retesting Tissue Donors to Decrease Communicable Disease Risk
January 25, 2007
Establishments that make donor eligibility determinations for certain human cells, tissues and cellular and tissue-based products (HCT/P) should retest donors to ensure that faulty testing methods do not allow communicable diseases to be transmitted through these products, according to the FDA.